Related Experiment Video

Updated: May 6, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

1.1K

Hedgehog pathway agonism: therapeutic potential and small-molecule development

M Kyle Hadden1

  • 1Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, CT 06269 (USA). kyle.hadden@uconn.edu.

Chemmedchem
|November 9, 2013
PubMed

Insights

The Hedgehog (Hh) pathway is crucial in development and cancer. This review focuses on small-molecule Hh agonists, exploring their potential for treating degenerative diseases.

Area of Science:

  • Developmental Biology
  • Oncology
  • Pharmacology

Background:

  • The Hedgehog (Hh) pathway is a critical signaling pathway involved in embryonic development and adult tissue homeostasis.
  • Aberrant Hh signaling is implicated in various cancers, leading to extensive research on pathway inhibitors for chemotherapy.
  • Conversely, activating the Hh pathway is a potential therapeutic strategy for degenerative and ischemic conditions, though less explored than inhibition.

Purpose of the Study:

  • To review recent evidence supporting the therapeutic potential of Hh pathway activators.
  • To provide a comprehensive overview of small-molecule Hh agonists.

Main Methods:

  • Literature review of recent studies on Hh pathway activators.
  • Analysis of small-molecule Hh agonists and their therapeutic applications.

Main Results:

  • Recent research highlights the therapeutic promise of Hh pathway activation.
  • A growing body of evidence supports the use of small-molecule Hh agonists.

Conclusions:

  • Small-molecule Hh agonists represent a promising therapeutic avenue for degenerative and ischemic disorders.
  • Further research and development of Hh agonists are warranted for clinical applications.
Keywords:
Hedgehog signalingSmoothenedagonistsneurodegenerativeosteodegenerative

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.0K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.1K

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

1.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.1K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.4K